AMCX is down -39.7% over the last three months and down -2.3% over the last six months. The stock has returned -35.2% over the last year.
Before we dig into the fundamental trends that drive the rating, let's look at a two-year stock chart with regression channel and 10-day momentum (on the bottom).
Note: You can change time horizons by clicking the or buttons near the bottom of the chart. You can examine a one minute day trading chart by clicking the at the top left corner of the chart.
What's Your Most Critical Stock?
AMC Networks Inc (AMCX) Trade Card™
Fundamentals
➜ AMCX generates $1.2332 in revenue for every $1 in expense, which is extremely high and extraordinarily above the sector average of $0.00.Although we find ourselves in an aging bull market where thousands of companies are making new highs in revenue, AMCX's revenue (TTM) is down from a year ago ($3.10 billion), and from two-years ago ($3.08 billion). Revenue in the most recent year was $2.71 billion.
Technicals | Support: 10.02 | Resistance: 11.57
AMCX is hitting a technical breakdown right now. The stock has a one bull (lowest rated) technical rating because while it's trading above its 10-day moving average, it's down on e the day, trading below both the 50- and 200-day moving averages and the 10 day MA is below the 50 day MA ("swing death cross").
Earnings Estimates
Earnings Date
2018-02-22
2018-02-22
EPS
$1.51
$1.51
Revenue (Mean)
$
$
Revenue (Median)
$
$
Last Quarter (Actual)
$678.85 million
$678.85 million
Fundamentals Rating Summary
Metric | Current | 1yr Ago | 2yr Ago | Direction |
Revenue (TTM US$ Millions) |
2,712 | 3,097 | 3,078 | |
Operating Margin (QTR) |
1.23 | 1.23 | 1.27 | |
Net Income (TTM US$ Millions) |
201 | 11 | 280 | |
Cash from Operations (TTM US$ Millions) |
204 | 182 | 143 | |
Capital Expenditures (TTM US$ Millions) |
35 | 44 | 43 |
|
Stock Returns and Chart |
|
Click here to interact with this stock chart
Now let's examine the visualizations of the critical financial measures.
Enter Symbol | |
METRIC | CURRENT | 1YR AGO | 2YR AGO | DIRECTION |
Revenue (TTM US$ Millions) | 2,712 | 3,097 | 3,078 |
Revenue over the trailing twelve months (TTM) for AMCX is falling. For the most recent (annual) period the company reported $2.71 billion from $3.10 billion a year ago, or a -12.4% change. The two-year change in revenue (TTM) is $-365.73 million (a -11.9% change). What do all these numbers mean? AMCX's fundamental rating was hit hard by these results: 1. The one-year change was negative. 2. The two-year change was negative. Let's look at Revenue (TTM US$ Millions) in the chart below. Click Here to Interact With This Chart |
Enter Symbol | |
METRIC | CURRENT | 1YR AGO | 2YR AGO | DIRECTION |
Operating Revenues/Operating Expense | 1.23 | 1.23 | 1.27 |
Operating Revenues/Operating Expense Operating revenue over operating expense simply shows us how much revenue (in dollars) is generated for every dollar of expense. The ratio must be (at a minimum) above 1.0 in order for a company to turn an operating profit. For the latest quarter AMCX showed a ratio of 1.23. What do all these numbers mean? A year ago Operating Revenues/Operating Expense was 1.23. In the last year we can see operating margins are increasing and are also currently greater than 1.0 (the critical level). AMCX's fundamental rating was affected from the operating margin numbers in two ways: 1. The current value is above 1.0 (the firm generates an operating profit). 2. The one-year change was positive (raises the rating). Let's look at Operating Revenues/Operating Expense in the chart below with the total assets in the orange line. Click Here to Interact With This Chart |
METRIC | CURRENT | 1YR AGO | 2YR AGO | DIRECTION |
Net Income (TTM US$ Millions) | 201 | 11 | 280 |
Net Income (after tax profit) over the trailing twelve months (TTM) for AMCX is rising. For the most recent trailing-twelve-months (TTM) the company reported net income of $201 (million). That's an increase in the most recent year from $11 (million) or a 1,726.26% change. In our next chart we plot Net Income (TTM US$ Millions) in the blue bars and the quarterly results in the gold line. Note the rising bars from a year ago (four quarters ago). Click Here to Interact With This Chart |
METRIC | CURRENT | 1YR AGO | 2YR AGO | DIRECTION |
Cash from Operations (TTM US$ Millions) | 204 | 182 | 143 |
Cash from Operations (TTM US$ Millions) is a critical determinant of stock price since market cap is the present value of all future free cash flows. For AMCX the metric is falling (it was $182 million last year). For the most recent trailing-twelve-months the company reported Cash from Operations (TTM US$ Millions) of $204 million. That's an increase in the most recent year from $182 million or a 12.15% rise. This cash metric is up $60 million from $143 million two-years ago. For our next chart we plot Cash from Operations (TTM US$ Millions) in the blue bars through time. Note the falling bars from a year ago (four quarters ago). Click Here to Interact With This Chart |
METRIC | CURRENT | 1YR AGO | 2YR AGO | DIRECTION |
Capital Expenditures (TTM US$ Millions) | 35 | 44 | 43 |
Capital Expenditures (TTM US$ Millions) is trending lower meaning that for at least five consecutive quarters, it's been dropping. Several consecutive drops in capital expenditures may be a red flag for a trend of under investment in the future. Note the trend in the chart below. Capital Expenditures (TTM US$ Millions) in the most recent quarter for AMCX was $35 million. CapEx is falling (-20.48%) from last year's value of $44 million. Further, we can see that CapEx today relative to two-years ago is decreasing (-17.30%) from last year's value of $43 million. In our final time series chart we plot Capital Expenditures (TTM US$ Millions) in the blue bars. Note the falling bars from one-year ago. Click Here to Interact With This Chart |
The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. Capital Market Laboratories ("The Company") does not engage in rendering any legal or professional services by placing these general informational materials on this website.
The Company specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses. The Company make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that The Company endorses, sponsors, promotes or is affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated. |